Reviva Pharmaceuticals Hldg Inc
(RVPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 05-2019 | 02-2019 | 12-2018 | 11-2018 | 08-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 274 | 313 | 313 | 401 | 442 |
| Other current assets | 0 | 0 | 91 | 0 | 0 |
| TOTAL | $338 | $404 | $404 | $462 | $520 |
| Non-Current Assets | |||||
| Investments And Advances | 65,652 | 65,242 | 64,877 | 64,877 | 64,535 |
| TOTAL | $65,652 | $65,242 | $64,877 | $64,877 | $64,535 |
| Total Assets | $65,989 | $65,646 | $65,646 | $65,339 | $65,055 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 28 | 23 | 22 | 22 | 2 |
| TOTAL | $28 | $23 | $23 | $22 | $2 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 60,962 | 60,623 | 60,316 | 60,317 | 60,053 |
| TOTAL | $60,962 | $60,623 | $60,316 | $60,317 | $60,053 |
| Total Liabilities | $60,989 | $60,646 | $60,646 | $60,339 | $60,055 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,265 | N/A | N/A | 8,265 | 8,265 |
| Common Shares | 4,088 | 4,426 | 4,732 | 4,732 | 4,996 |
| Retained earnings | 913 | 574 | 574 | 268 | 4 |
| Other shareholders' equity | 0 | 0 | -306 | 0 | 0 |
| TOTAL | $5,000 | $5,000 | $5,000 | $5,000 | $5,000 |
| Total Liabilities And Equity | $65,989 | $65,646 | $65,646 | $65,339 | $65,055 |